Dr. Peter McCullough has published a new paper with the European Society of Medicine that outlines a potential cure for Long Covid and Vaccine Injury Syndromes. His research identifies the spike protein from the SARS-CoV-2 virus and from COVID-19 mRNA vaccines as a major cause of these syndromes. Evidence suggests that this spike protein can remain in the body for an extended time, which may lead to a cycle of ongoing health issues. The vaccine does not prevent infections, leading to repeated exposure to the spike protein, potentially harming the immune system's ability to respond to new virus variants.
The treatment focus emphasizes eliminating the foreign spike protein from the body. Some people doubt the existence of Long Covid, viewing it as a mental or hormone-related issue. However, McCullough's clinical experience shows that even unvaccinated patients can suffer significant health problems linked to high spike antibody levels.
Among vaccinated individuals, a clear symptom of vaccination-related health issues is myocarditis, which has been noted by the CDC, despite efforts to downplay its occurrence. Over the past three years, McCullough has been searching for safe and effective ways to remove the spike protein. Although there is no single cure like penicillin for syphilis, he has developed a detoxification protocol involving over-the-counter supplements such as Nattokinase, Bromelain, and Curcumin. For myocarditis, colchicine is included in the regimen.
A recent paper co-authored by McCullough and others describes a case of a 23-year-old man who developed myocarditis after vaccination. His treatment included a detoxification protocol and colchicine, which helped improve his heart failure but did not completely alleviate chest pain. The addition of rapamycin, an off-label medication, proved effective in reducing inflammation and improving his quality of life.
Rapamycin, derived from a bacterial source, has been used in various medical applications, including preventing organ rejection and treating specific rare diseases. It shows promise as a potential treatment for vaccine-related cardiac injuries, alongside the detoxification methods developed by McCullough.
With this publication, McCullough and his team aim to establish the first standard care for these conditions, though the approach is still developing. Further investigation is necessary to refine these methods. Readers who wish to learn more about the detoxification protocol and the new findings are encouraged to check out more detailed posts from Nicolas Hulscher.
Readers who want to delve deeper into the details of the McCullough detoxification protocol and this new paper are encouraged to read Nicolas Hulscher’s post of this morning: BREAKING - New Peer-Reviewed Study: Resolution of Refractory COVID-19 Vaccine-Induced Myopericarditis with Adjunctive Rapamycin
https://petermcculloughmd.substack.com/p/a-cure-to-long-covid-and-vaccine
No comments:
Post a Comment